Generation and analysis of anti-ganglioside antibodies for the immunotherapeutic treatment of high-risk neuroblastoma

to related objects

Alternative title: Generation und Analyse von Anti-Gangliosid Antikörpern für die immuntherapeutische Behandlung beim Hochrisiko-Neuroblastom

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Hamburg, Universität Hamburg, Dissertation, 2023

Keyword: Immuntherapie
Antikörper
Krebs
Therapie
Kind
Ganglioside
Neuroblastom
Antikörper
Immuntherapie
Immunologie
Onkologie

Event: Veröffentlichung

(where): Hamburg

(who): Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky

(when): 2023

Creator: Rekowski, Laura

Contributor: Müller, Ingo

URN: urn:nbn:de:gbv:18-ediss-113867

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rekowski, Laura
Müller, Ingo
Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky

Time of origin

2023

Other Objects (12)

Anti-ganglioside antibodies and celiac disease

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Hochschulschrift

Ganglioside als Virusrezeptoren

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Hochschulschrift

Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside

Functional validation of novel target structures for treatment of high-risk neuroblastoma

GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells

Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity

Anti-ganglioside antibodies and celiac disease

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Hochschulschrift

Ganglioside als Virusrezeptoren

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Hochschulschrift

Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside

Functional validation of novel target structures for treatment of high-risk neuroblastoma

GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells

Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity

Anti-ganglioside antibodies and celiac disease

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Hochschulschrift

Ganglioside als Virusrezeptoren

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Hochschulschrift

Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside

Functional validation of novel target structures for treatment of high-risk neuroblastoma

GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells

Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Generation and analysis of anti-ganglioside antibodies for the immunotherapeutic treatment of high-risk neuroblastoma

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Anti-ganglioside antibodies and celiac disease

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Ganglioside als Virusrezeptoren

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside

Functional validation of novel target structures for treatment of high-risk neuroblastoma

GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells

Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity

Anti-ganglioside antibodies and celiac disease

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Ganglioside als Virusrezeptoren

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside

Functional validation of novel target structures for treatment of high-risk neuroblastoma

GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells

Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity

Anti-ganglioside antibodies and celiac disease

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Ganglioside als Virusrezeptoren

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside

Functional validation of novel target structures for treatment of high-risk neuroblastoma

GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells

Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity

Related objects

Reset password